Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

1.

microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.

Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen L, Hang W, Ruan A, Yang H, Zhang X.

Oncol Rep. 2013 Aug;30(2):643-50. doi: 10.3892/or.2013.2530. Epub 2013 Jun 7.

PMID:
23754305
[PubMed - indexed for MEDLINE]
2.

Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.

Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.

J Pathol. 2008 Dec;216(4):418-27. doi: 10.1002/path.2437.

PMID:
18925646
[PubMed - indexed for MEDLINE]
3.

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H.

Oncotarget. 2012 Jan;3(1):44-57.

PMID:
22294552
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.

Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q.

Oncol Rep. 2013 Apr;29(4):1579-87. doi: 10.3892/or.2013.2267. Epub 2013 Jan 31.

PMID:
23381389
[PubMed - indexed for MEDLINE]
5.

MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A.

Gut. 2013 Sep;62(9):1315-26. doi: 10.1136/gutjnl-2011-301846. Epub 2012 Jun 26.

PMID:
22735571
[PubMed - indexed for MEDLINE]
6.

Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.

Huang J, Yao X, Zhang J, Dong B, Chen Q, Xue W, Liu D, Huang Y.

Cancer Sci. 2013 Dec;104(12):1609-17. doi: 10.1111/cas.12291. Epub 2013 Oct 27.

PMID:
24112779
[PubMed - indexed for MEDLINE]
7.

Targets of miR-200c mediate suppression of cell motility and anoikis resistance.

Howe EN, Cochrane DR, Richer JK.

Breast Cancer Res. 2011 Apr 18;13(2):R45. doi: 10.1186/bcr2867.

PMID:
21501518
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.

Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H.

Cancer Sci. 2013 Jan;104(1):48-54. doi: 10.1111/cas.12030. Epub 2012 Nov 8.

PMID:
23013135
[PubMed - indexed for MEDLINE]
9.

Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.

Yoshino H, Enokida H, Itesako T, Tatarano S, Kinoshita T, Fuse M, Kojima S, Nakagawa M, Seki N.

J Hum Genet. 2013 Aug;58(8):508-16. doi: 10.1038/jhg.2013.31. Epub 2013 May 2.

PMID:
23635949
[PubMed - indexed for MEDLINE]
10.

Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.

Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.

Int J Oncol. 2012 Sep;41(3):805-17. doi: 10.3892/ijo.2012.1543. Epub 2012 Jul 3.

PMID:
22766839
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.

Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.

J Urol. 2013 Sep;190(3):1059-68. doi: 10.1016/j.juro.2013.02.089. Epub 2013 Feb 27.

PMID:
23454155
[PubMed - indexed for MEDLINE]
12.

MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.

Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S656-64. doi: 10.1245/s10434-012-2217-6. Epub 2012 Feb 4.

PMID:
22311119
[PubMed - indexed for MEDLINE]
13.

Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.

Manavalan TT, Teng Y, Litchfield LM, Muluhngwi P, Al-Rayyan N, Klinge CM.

PLoS One. 2013 Apr 23;8(4):e62334. doi: 10.1371/journal.pone.0062334. Print 2013.

PMID:
23626803
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.

Hurteau GJ, Carlson JA, Spivack SD, Brock GJ.

Cancer Res. 2007 Sep 1;67(17):7972-6.

PMID:
17804704
[PubMed - indexed for MEDLINE]
Free Article
15.

miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.

Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA, Yousef GM.

Carcinogenesis. 2013 Oct;34(10):2231-9. doi: 10.1093/carcin/bgt184. Epub 2013 May 28.

PMID:
23715501
[PubMed - indexed for MEDLINE]
16.

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

Korpal M, Lee ES, Hu G, Kang Y.

J Biol Chem. 2008 May 30;283(22):14910-4. doi: 10.1074/jbc.C800074200. Epub 2008 Apr 14.

PMID:
18411277
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.

Chen ML, Liang LS, Wang XK.

Clin Exp Metastasis. 2012 Jun;29(5):457-69. doi: 10.1007/s10585-012-9463-7. Epub 2012 Mar 10.

PMID:
22407310
[PubMed - indexed for MEDLINE]
18.

Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.

Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT, Pang RW.

PLoS One. 2013;8(3):e57882. doi: 10.1371/journal.pone.0057882. Epub 2013 Mar 6.

PMID:
23483935
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.

Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, Papotti M, Allgayer H.

Int J Cancer. 2012 May 1;130(9):2044-53. doi: 10.1002/ijc.26218. Epub 2011 Aug 8.

PMID:
21633953
[PubMed - indexed for MEDLINE]
20.

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.

Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK.

Mol Cancer Ther. 2009 May;8(5):1055-66. doi: 10.1158/1535-7163.MCT-08-1046. Epub 2009 May 12.

PMID:
19435871
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk